Add to BibSonomy
Abstract
Photonic biosensors that use optical resonances to amplify signals from refractive index changes offer high sensitivity, real-time readout, and scalable, low-cost fabrication. However, when used with classic affinity assays, they struggle with noise from nonspecific binding and are limited by the low refractive index and small size of target biological molecules. In this Letter, we evaluate the performance of an integrated microring photonic biosensor using the high contrast cleavage detection (HCCD) mechanism, which we recently introduced. The HCCD sensors make use of dramatic optical signal amplification caused by the cleavage of large numbers of high-contrast nanoparticle reporters instead of the adsorption of labeled or unlabeled low-index biological molecules. We evaluate the advantages of the HCCD detection mechanism over conventional target-capture detection techniques with the same label and the same sensor platform, using an example of a silicon ring resonator as an optical transducer decorated with silicon nanoparticles as high-contrast reporters. In the practical realization of this detection scheme, detection specificity and signal amplification can be achieved via collateral nucleic acid cleavage caused by enzymes such as CRISPR Cas12a and Cas13 after binding to a target DNA/RNA sequence in solution.
© 2021 Optical Society of America
Full Article | PDF ArticleMore Like This
Rabeb Layouni, Michael Dubrovsky, Mengdi Bao, Haejun Chung, Ke Du, Svetlana V. Boriskina, Sharon M. Weiss, and Diedrik Vermeulen
Opt. Express 29(1) 1-11 (2021)
Haejun Chung and Svetlana V. Boriskina
Opt. Express 29(7) 10780-10799 (2021)
Hsin-Yu Yao and Tsing-Hua Her
Opt. Lett. 46(4) 721-724 (2021)